Bifogade filer
PDF
NextCell Pharma AB ("NextCell" or the "Company") today announces that the Company's CFO, Patrik Fagerholm, has decided to step down to take on a new assignment. Patrik will remain in his role throughout the notice period to ensure a smooth transition. The recruitment process to identify a successor for the CFO position has been initiated.
What was initially intended as a one-year interim solution developed into four years of close collaboration, during which Patrik played a central role in building NextCell Pharma AB into a group comprising the subsidiaries Cellaviva and QVance.
"We would like to extend our sincere thanks to Patrik for his dedication and valuable contributions over the years. His efforts have been both more extensive and longer-lasting than originally planned, and we wish him every success in his future career," says Mathias Svahn, CEO of NextCell Pharma.